Abena Antimicrobial Glove

Similar documents
99.999% KILLS UP TO. MICROBES to help prevent healthcare-associated Infections

Chapter 12. Preventing Infection. Elsevier items and derived items 2014, 2010 by Mosby, an imprint of Elsevier Inc. All rights reserved.

Chapter 11 PREVENTING INFECTION. Elsevier items and derived items 2010 by Mosby, Inc. an affiliate of Elsevier Inc. All rights reserved

Chapter 13. Preventing Infection. Copyright 2019 by Elsevier, Inc. All rights reserved.

This program will outline infection prevention measures known to help reduce the risk of patients getting a healthcare associated infection (HAI).

Lourdes Hospital Infection Prevention and Control

Doc: 1.9. Course: Patient Safety Solutions. Topic: Infection prevention and control. Summary

Preventing & Controlling the Spread of Infection

feeling Stay in touch with your second skin

Infection Control and Asepsis. Copyright 2010, 2006 by Saunders, an imprint of Elsevier Inc. All rights reserved.

CH. 24. The Immune System

Infection Control Basics:

INFECTION CONTROL PRACTICES

BIP Endotracheal Tube

Application Guide for Full-Thickness Wounds

PRINCIPLES AND PRACTICES OF ASEPSIS OBJECTIVES

3/26/2014 OBJECTIVES PRINCIPLES AND PRACTICES OF ASEPSIS DEFINING ASEPSIS MEDICAL ASEPSIS PRINCIPLES OF MEDICAL ASEPSIS

Lecture 10 Immune System

MODULE B. Objectives. Infection Prevention. Infection Prevention. N.C. Nurse Aide I Curriculum

Staph Infection Fact Sheet

APPLIED EDUCATIONAL SYSTEMS. Infection Control. Health Science and Technology Education. Table of Contents

Keyboards and mice as a cross contamination risk in the medical setting

DRY HANDS SAFETY BRIEFING

Infection Control Sec. 1, Unit 5 Part 1

Small living organism Not visible to the naked eye Must be viewed under a microscope Found everywhere in the environment, including on and in the

Infection Prevention and Control Induction Program. GRICG May 2015

OBJECTIVES PEOPLE AS RESERVOIRS. Reservoir

Principles and Practices of Asepsis

Hand Hygiene: Preventing avoidable harm in our care

EPIDEMIOLOGY AND RISK OF INFECTION IN DENTAL SETTINGS

Infection Prevention Prevention and Contr

Infection Control. Copyright 2011, 2007, 2003, 1999 by Saunders, an imprint of Elsevier Inc. All rights reserved.

Standard Precautions & Isolation Precautions. If you have questions about this module, contact the Infection Prevention department at your facility.

Chapter 12 Preventing Infection

Pulpdent Corporation Revision Date: May 1, 2017

LEARNING MODULE: INFECTION CONTROL BLOODBORNE PATHOGENS ISOLATION PRECAUTIONS PHARMACEUTICAL WASTE

Self-Instructional Packet (SIP)

Infection Prevention and Control - General Orientation

ISOPA PRODUCT STEWARDSHIP PROGRAMMES. Walk the Talk MDI USERS. 1 Version09/06

HYPOCHLOROUS ACID (HOCl) Our Body's immune system protector in a BOTTLE

Zambia infection prevention guidelines & application in health care facilities

Infection Control. Student Orientation

Lecture 10 Immune System

PEGCO Inc. 532 N. RIDGEWOOD AVE DAYTONA BEACH, FL Phone: (386) Fax (386)

Types of infections & Mode of transmission of diseases

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae

Cleaning for Infection

MICROBIOLOGICAL PROFILE

The Chain of Infection

At the end of this presentation, you will be able to:

FERTISAFE PLUS US PL AFE TIS FER

Infection Control Blood Borne Pathogens. Pines Behavioral Health

Limits of Current Hand Hygiene, and the Search for Solutions. Jesse Cozean

"GUARDING AGAINST TUBERCULOSIS AS A FIRST RESPONDER"

2018 Ascension Infection Prevention. 1. Course. 1.1 Infection Prevention. 1.2 Main Objectives

Infection Control in the School Setting. It s In Your Hands

Enhanced EARS-Net Surveillance 2017 First Half

Learning Objectives. Identify the best ways to prevent healthcareassociated

Introducing the World s First Self-Sanitizing UV Germicidal Keyboard and Mouse Solution

WELCOME TO Scott &White Infection Prevention

OZONE EFFECTS ON SPECIFIC BACTERIA AND VIRUSES (

SAFETY DATA SHEET HANNILASE XP 1050 NB Version: 1 GHS / EN Revision Date:

Questions and Answers about

Infection Control in the Health Care Setting

Appendix C. RECOMMENDATIONS FOR INFECTION CONTROL IN THE HEALTHCARE SETTING

2514 Stenson Dr Cedar Park TX Fax

Chain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host

Occupational exposure to bloodborne pathogens

2/11/ Six elements of infection: (portal of exit)

Material Safety Data Sheet

End Vinyl Glove Worries. Relax with Lavender *.

Unit 1: Asepsis and Infection Control

PROTECT YOURSELF FROM TYPE I ALLERGIES.

Group A Streptococcus

HealthStream Regulatory Script

Latex and Occupational Dermatitis Policy Incorporating Glove Selection

MATERIAL SAFETY DATA SHEET

Epidemiology and Risk of Infection in outpatient Settings

Epidemiology and Risk of Infection in outpatient Settings

Infection Prevention and Control Annual Education Authored by: Infection Prevention and Control Department

Safety Data Sheet THE CRACKER Created On: 03/13/2015 Revision Date: 02/29/16 Version: 3.0

Medical/Surgical Asepsis. Presented by: Cynthia Bartlau, RN, PHN, MSN

Dangers of NOT Cleaning Your Hands

Blood Borne Pathogens

MATERIAL SAFETY DATA SHEET In accordance with CE Regulation n 1907/2006. Annex II.

HOSPITAL INFECTION CONTROL

The 1 st Step in Infection Control is Hand Hygiene

Powerful Germ Kill, PURELL Peace of Mind.

Infection Control for Anesthesia Personnel

Antimicrobial resistance Fact sheet N 194 Updated April 2014

SAFETY DATA SHEET. Section 1: Identification of the Substance/Mixture and of the Company/Undertaking

ISOPA PRODUCT STEWARDSHIP PROGRAMMES. Walk the Talk MDI USERS

Powerful Germ Kill, PURELL Peace of Mind.

Pulpdent Corporation Revision Date: January 1, 2014

ISOPA PRODUCT STEWARDSHIP PROGRAMMES. Walk the Talk MDI USERS

June 4, Page 1 of 5 POLICY STATEMENT

Safety Data Sheet SECTION 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING

Naturally derived Alcohol free Proven efficiency

Chapter 38- Immune System

Material Safety Data Sheet according to 91/155/EEC - ISO

Transcription:

Abena Antimicrobial Glove Revolutionizing the world of infection prevention The first non-leaching antimicrobial nitrile glove Provides active protection against HAIs Kills up to 99.999% of selected bacteria

Revolutionizing the world of infection prevention Benefits of Abena Antimicrobial Gloves World s 1st non-leaching antimicrobial gloves Kills up to 99.999% of selected bacteria Provides active protection against HAIs Tested non-sensitising on skin A gamechanger for Healthcare associated infections Every year, Healthcare associated infections cause unnecessary suffering and increasing medical costs for millions of patients and their families around the world. These infections prolong hospital stays, increase the risk of post-operative complications and disabilities, increase resistance to antibiotics, and even result in unnecessary deaths and massive financial losses to the healthcare system. EU Affected Patients 4.1 million Deaths 37.000 Cost approx. 7 billion EUR USA Affected Patients 1.7 million Deaths 99.000 Cost approx. 6.5 billion USD Annual impact of HAI in the USA and Europe Source : Adapted from World Health Organization, Healthcare-Associated Infections Fact Sheet.

Introducing a new approach to Healthcare Our needs as individuals and healthcare providers are changing every day. We live longer. We face challenges of multiresistant bacteria and a growing population over the age of 80. It is more important than ever that we keep our focus on tomorrow s essential healthcare needs. Abena Antimicrobial Gloves As the first glove in the world to offer high levels of antimicrobial protection while being non-leaching, Abena Antimicrobial Gloves are a gamechanger for the world of infection prevention. Abena Antimicrobial Gloves are a new type of medical examination glove with built-in antimicrobial technology to fight infection and combat antimicrobial resistance Activated by light and oxygen, and able to kill up to 99.999% of microbes, Abena Antimicrobial Gloves provide an extra active layer of protection to healthcare around the world. Key features Effective against a wide range of microbes Photodynamic quick kill Non-leach technology Allround glove applications No impact on bacterial resistance Proven skin-safe

An active approach in preventing HAIs Abena Antimicrobial Gloves play an active role in reducing the spread of infections While conventional medical gloves serve only as a passive barrier between microbes and your hands, Abena Antimicrobial Gloves actively reduce the risk of infection transmission from an infection source to a susceptible patient. What are Healthcare Associated Infections? Healthcare-associated infections include infections developed as a result of medical care in a hospital or healthcare facility, which was neither present nor incubating at the time of admission. It includes infections acquired by patients in the medical facility as well as occupational infections among staff. About Healthcare Associated Infections Chain of Infection Clinical studies show that medical gloves play a key role in preventing contamination, dissemination and transmission of pathogens in healthcare settings, which is why The World Health Organization (WHO) recommends wearing medical gloves. Enterococcus faecalis (VRE) is responsible for 80% of human infections. Source (Reservoir) People, environment Means of Transmission (Vehicle) Physical contact, droplets, air and sharps injuries Susceptible Person Non-vaccinated, weakened immune system Infections occur when microbes enter the body, breed and cause a reaction to the body. Three things lead to an infection: a source, a susceptible person, and the transmission (vehicle).

Photodynamic quick kill ACTIVATED PHOTOSENSITISER REACTIVE OXYGEN SPECIES (ROS) Kills microorganisms quickly upon contact The active ingredient on the glove is a photosensitizer which generates singlet oxygen when exposed to light. This singlet oxygen oxidizes the bacteria s protein and lipid, thus leading to the death of microbes. Independent testing has shown that bacteria coming into contact will be exposed to the antimicrobial activity and will be killed within just five minutes of contact. This technological breakthrough is based on many years of thorough and groundbreaking antimicrobial research. Ultimately, Abena s Antimicrobial Gloves help reduce the risk of transmission from an infection source to a susceptible patient. This technology, built into gloves, which are already standard practice in many medical and healthcare settings, also removes the need for additional solutions and chemicals. ACTIVATED PHOTOSENSITISER LIGHT 1 O2 MICROBES CELL DEATH No impact on bacterial resistance The potential for development of bacterial resistance to the active has been assessed as low. This is attributed to the nonspecific nature of the glove s bacteria-killing mechanism. Generally, oxidative antimicrobials such as the AMG technology is viewed as having low probability for development of resistance by the EU Scientific committee. Abena Antimicrobial Gloves kill 99.999% of selected microbes* Bactericidal Efficacy of Abena Antimicrobial Gloves* MRSA 99.988% in 5 minutes Staphylococcus aureus 99.999% in 5 minutes Enterococcus faecium 99.991% in 5 minutes Enterococcus faecalis (VRE) 99.982% in 5 minutes Streptococcus pyogenes 99.946% in 5 minutes Klebsiella pneumoniae 96.471% in 10 minutes E-Coli 99.030% in 15 minutes *Based on ASTM D7907 Standard Test Methods for Determination of Bactericidal Efficacy on the Surface of Medical Examination Gloves, AMG is effective in killing prevalent and antibiotic resistant microbes such has MRSA and VRE. Test data has shown that AMG can kill 99.999% of some microbes in as quickly as 5 minutes. Test result available upon request.

Features Groundbreaking Non-leach Technology Abena Antimicrobial Gloves are the world s first non-leaching antimicrobial gloves. The active has been tested for non-migration with the following medium: Water Hot water (45 degrees celcius) Sweat Saliva Ethanol All-round Glove Applications Abena s Antimicrobial Gloves have been proven safe for use for different applications and industries. Medical Tested for impermeability and glove strength, AMG glove is effective in preventing contamination between patient and healthcare practitioner, as well as for handling various chemotherapy drugs. All tests conducted are in accordance to recognized international standards such as ASTM D6319, EN 455 and ISO 11193 part 1. PPE (Personal Protective Equipment) The glove is tested to protect users from substances and mixtures that are hazardous to health, and harmful biological agents that may cause very serious consequences or damage to health. Tests conducted are in accordance to the harmonized standards which complies with PPE Regulation. Proven Skin-safe Abena Antimicrobial Gloves have been tested safe for use against various contacts. These tests confirm that the AMG glove is: Non-irritating: does not cause primary skin irritation like redness (erythema) or slight swelling (edema). Non-sensitizing: does not contain any substance that will induce skin allergy. Non-toxic: No toxic effects occurring following oral administration. Non-cytotoxic: does not display destructive action on cells. Non-sensitizer & low dermatitis potential: Modified Draize Test shows no allergic reaction in normal tissue after exposure

FAQ Do antimicrobial gloves replace the need for hand hygiene? Although the glove has been found effective against a wide range or microbes, it does not replace the need for hand hygiene. AMG serves as an extra precaution or tool to help mitigate the spread of HAI. Protocols for hand rubbing or hand washing should still be performed before donning and after removing gloves. What does non-leaching mean? Is it safe? The antimicrobial gloves are designed to be non-leaching in order to ensure the active ingredient does not transfer to the patient. To further ensure the safety of the active ingredient, the gloves have been tested for biocompatibility. ISO 10993 biocompatibility testing conducted on the inside and external surface of the gloves have confirmed that the gloves are non-sensitizing, non-irritating, non-toxic (oral) and non-cytotoxic. The Modified Draize-95 test was also conducted where both the inner and outer surfaces of the gloves were tested on human skin. The gloves provided no clinical evidence of inducing allergic reactions. Finally, tested at Intertek UK, the gloves were extracted using water, artificial saliva, artificial sweat and alcohol at room and body temperature.. No active could be found extracted from the gloves inner or outer surface. How does singlet oxygen work? In this technology a special dye is used. The dye absorbs visible light. The dye is thus raised from a ground state to an excited quantum state, in which an elevation in energy takes place. The energy then transfers to a proximal oxygen molecule found in the air, causing the oxygen molecule to also rise to an excited quantum state. The ground state of oxygen present in air, is a triplet electronic configuration. Upon sensitization by the dye molecule, the electronic configuration changes and enters the singlet state. This singlet oxygen state is reactive and more oxidative compared to ground state oxygen and therefore, is able to kill microbes such as bacteria by oxidizing the cells protein and lipid. Using the dye as a catalyst, singlet oxygen can be generated continuously as it absorbs light and air. What are the advantages of using singlet oxygen antimicrobial systems? Singlet oxygen is a non-selective system that can react rapidly against many microbial components. There is not one single protection mechanism that bacteria can protect itself from singlet oxygen. This is in contrast to antibiotics, which needs very specific mechanisms to treat a patient. As singlet oxygen is transient, it does not lead to the release of persistent biocides into the environment. As such, Abena Antimicrobial Gloves transforms the standard examination glove from a passive medical device to a medical device with active protection, which will actively reduce or inhibit microbial colonization. What is the amount of light needed to activate the Antimicrobial Gloves? Testing of AMG glove has been conducted at general lighting condition at hospitals of 1000 lux and 500 lux. Results show that there was no significant difference in bactericidal efficacy. Further testing at lower light levels are underway. Would differences in lighting type affect the efficacy of Antimicrobial gloves (for example LED, fluorescent, incandescent light bulb)? No. The glove is activated by any white light source. It is specifically activated by light in the 600-700 nm region but all white light sources contain this, otherwise they would be colored. Will the dye be depleted if the Antimicrobial Gloves are continually exposed to light? No. As long as there is light and oxygen, the gloves are active. Heat-aged gloves (accelerated aging equivalent to 3 years shelf life) did not show significant difference in bactericidal efficacy compared to fresh gloves. The gloves were also exposed to light (equivalent to 30 days in an open box environment). Again, there was no significant difference in bactericidal efficacy compared to fresh gloves. See how Abena Antimicrobial Gloves are revolutionizing the future of healthcare: www.abena.com/antimicrobialgloves

Abena. Egelund 35. 6200 Aabenraa Tlf. 74 31 18 18. info@abena.dk. www.abena.com BR901/GLOBAL/11.2018/Abena Group Marketing